Circulating Tumor Cells Measurements in Hepatocellular Carcinoma
Liver cancer is the fifth most common cancer in men and the seventh in women. During the past 20 years, the incidence of HCC has tripled while the 5-year survival rate has remained below 12%. The presence of circulating tumor cells (CTC) reflects the aggressiveness nature of a tumor. Many attempts h...
Saved in:
Main Author: | Franck Chiappini |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | International Journal of Hepatology |
Online Access: | http://dx.doi.org/10.1155/2012/684802 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Early release of circulating tumor cells after transarterial chemoembolization hinders therapeutic response in patients with hepatocellular carcinoma
by: María L. Espejo-Cruz, et al.
Published: (2025-01-01) -
Harnessing nanoparticles for reshaping tumor immune microenvironment of hepatocellular carcinoma
by: JinSong Li, et al.
Published: (2025-02-01) -
Adrenal Rest Tumor of the Liver Preoperatively Diagnosed as Hepatocellular Carcinoma
by: Megumu Enjoji, et al.
Published: (2017-01-01) -
Characterization of tumor evolution by functional clonality and phylogenetics in hepatocellular carcinoma
by: Zeynep Kacar, et al.
Published: (2024-03-01) -
Metastatic Periampullary Tumor from Hepatocellular Carcinoma Presenting as Gastrointestinal Bleeding
by: Amir Kashani, et al.
Published: (2015-01-01)